Express Pharma

‘We believe our effort will result in a broad-spectrum antiviral to address future outbreaks’

0 766

Dr Nir London, Senior Scientist, Department of Organic Chemistry, The Weizmann Institute of Science, has brought together a wide range of players—from academia in four countries, to biotech and contract research organisations, to specialised software companies— to accelerate the development of a drug against COVID-19. Dr London reveals more details about